“…There is also evidence to suggest that joint tissue derived multipotent stromal cells, such as those isolated from the infrapatellar fat pad (IFP) or synovium, may possess a superior chondrogenic potential to those derived from alternative sources (Sakaguchi et al, 2005;Vinardell et al, 2012b). In spite of this, the in vivo phenotypic stability of cartilaginous tissues engineered using such cells, irrespective of their origin, is by no means assured (De Bari et al, 2004;Pelttari et al, 2006;Hennig et al, 2007;Dickhut et al, 2008). Previous studies have shown that following in vivo subcutaneous implantation, IFP derived multipotent stromal cells (FPSCs) tend to undergo fibrous dedifferentiation or resorption, as evidenced by increased collagen type I and reduced sulphated glycosaminoglycan (sGAG) content, whereas bone marrow derived multipotent stromal cells (BMSCs) tend to follow an endochondral pathway, with increased mineralisation and vascularisation of the engineered tissue (Pelttari et al, 2006;Vinardell et al, 2012b).…”